» Articles » PMID: 30668697

Quantitative Proteomics by SWATH-MS of Maternal Plasma Exosomes Determine Pathways Associated With Term and Preterm Birth

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2019 Jan 23
PMID 30668697
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are membrane-bound nanovesicles that transport molecular signals between cells. This study determined changes in maternal plasma exosome proteomics contents in term and preterm births. Maternal plasma (MP) samples were collected from group 1: term not in labor (TNIL, n = 13); group 2: term in labor (TL, n = 11); group 3: preterm premature rupture of membranes (pPROM, n = 8); and group 4: preterm birth (PTB, n = 13). Exosomes isolated from plasma by differential density centrifugation followed by size exclusion chromatography were characterized by morphology (electron microscopy), quantity and size (nanoparticle tracking analysis), and markers (western blot). A quantitative, information-independent acquisition [sequential windowed acquisition of all theoretical mass spectra (SWATH-MS)] approach was used to determine the protein profile in exosomes. Ingenuity Pathway Analysis determined pathways associated with the protein profile identified in exosomes. MP exosomes were spherical, had a mean diameter of 120 nm, and were positive for exosomal proteins CD63 and TSG101 irrespective of pregnancy status. No distinct changes in exosome quantities were seen in maternal circulation across the groups. SWATH-MS identified 72 statistically significant proteins across the groups studied. Bioinformatics analysis showed the proteins within the exosomes in TNIL, TL, pPROM, and PTB target pathways mainly associated with inflammatory and metabolic signals. Exosomal data suggest that homeostatic imbalances, specifically inflammatory and endocrine signaling, might disrupt pregnancy maintenance resulting in labor-related changes both at term and preterm. Reflection of physiologic changes in exosomes is suggestive of its usefulness as biomarkers and cellular function indicators.

Citing Articles

Extracellular vesicles and preterm infant diseases.

Chen W, Kongsomros S, Thorman A, Esfandiari L, Morrow A, Chutipongtanate S Front Pediatr. 2025; 13:1550115.

PMID: 40034714 PMC: 11873092. DOI: 10.3389/fped.2025.1550115.


Exosomes in Oral Diseases: Mechanisms and Therapeutic Applications.

Miao Q, Li S, Lyu W, Zhang J, Han Y Drug Des Devel Ther. 2025; 19:457-469.

PMID: 39867866 PMC: 11766710. DOI: 10.2147/DDDT.S505355.


Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).

Paton M, Benders M, Blatch-Williams R, Dallimore E, Edwards A, Elwood N Pediatr Res. 2025; .

PMID: 39815092 DOI: 10.1038/s41390-025-03856-x.


Extracellular Vesicles as Biomarkers of Pregnancy Complications.

Popova A, Vashukova E, Illarionov R, Maltseva A, Pachuliia O, Postnikova T Int J Mol Sci. 2024; 25(22).

PMID: 39596014 PMC: 11594130. DOI: 10.3390/ijms252211944.


Analysis of the evolution of placental oxidative stress research from a bibliometric perspective.

Chen A, Tian M, Luo Z, Cao X, Gu Y Front Pharmacol. 2024; 15:1475244.

PMID: 39484166 PMC: 11524950. DOI: 10.3389/fphar.2024.1475244.


References
1.
Velez D, Fortunato S, Thorsen P, Lombardi S, Williams S, Menon R . Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. PLoS One. 2008; 3(9):e3283. PMC: 2553267. DOI: 10.1371/journal.pone.0003283. View

2.
Menon R, Bonney E, Condon J, Mesiano S, Taylor R . Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Hum Reprod Update. 2016; 22(5):535-60. PMC: 5001499. DOI: 10.1093/humupd/dmw022. View

3.
Menon R, Fortunato S, Velez Edwards D, Williams S . Association of genetic variants, ethnicity and preterm birth with amniotic fluid cytokine concentrations. Ann Hum Genet. 2010; 74(2):165-83. DOI: 10.1111/j.1469-1809.2010.00562.x. View

4.
Salomon C, Yee S, Scholz-Romero K, Kobayashi M, Vaswani K, Kvaskoff D . Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration. Front Pharmacol. 2014; 5:175. PMC: 4128075. DOI: 10.3389/fphar.2014.00175. View

5.
Kshirsagar S, Alam S, Jasti S, Hodes H, Nauser T, Gilliam M . Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta. 2012; 33(12):982-90. PMC: 3534832. DOI: 10.1016/j.placenta.2012.10.005. View